$NYC
American Strategic Investment Co. Stock $nyc

$nyc Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-Q Financial Statement

#000159552721000027 Filed on November 12, 2021

Income Statement

Concept	2021 Q4	2021 Q3	2020 Q3
Revenue	$24.21M	$300.0K	$17.00M
YoY Change	145.52%	-98.23%	-8.83%
Cost Of Revenue	$10.21M	$9.891M	$10.18M
YoY Change	-3.74%	-2.84%	1.9%
Gross Profit	$14.00M	$5.957M	$6.820M
YoY Change	-1966.0%	-12.65%	-21.25%
Gross Profit Margin	57.81%	1985.67%	40.12%
Selling, General & Admin	$4.223M	$4.005M	$2.950M
YoY Change	6.64%	35.76%	145.83%
% of Gross Profit	30.18%	67.23%	43.26%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$7.657M	$7.851M	$8.640M
YoY Change	-0.3%	-9.13%	10.77%
% of Gross Profit	54.71%	131.79%	126.69%
Operating Expenses	$11.88M	$11.86M	$11.59M
YoY Change	2.15%	2.3%	-38.97%
Operating Profit	$2.115M	-$6.312M	-$7.218M
YoY Change	-117.08%	-12.55%	1968.19%
Interest Expense	-$4.811M	$4.803M	$5.089M
YoY Change	13.74%	-5.62%	8.72%
% of Operating Profit	-227.47%
Other Income/Expense, Net	$3.000K	-$4.798M	-$5.070M
YoY Change	-70.0%	-5.36%	13.68%
Pretax Income	-$3.732M	-$11.11M	-$12.29M
YoY Change	-77.52%	-9.59%	155.47%
Income Tax	$23.00K	$14.00K	$0.00
% Of Pretax Income
Net Earnings	-$3.755M	-$11.12M	-$12.29M
YoY Change	-77.38%	-9.47%	155.52%
Net Earnings / Revenue	-15.51%	-3708.0%	-72.3%
Basic Earnings Per Share		-$0.85	-$0.96
Diluted Earnings Per Share	-$283.3K	-$0.85	-$0.96
COMMON SHARES
Basic Shares Outstanding	13.28M shares	13.09M shares	12.77M shares
Diluted Shares Outstanding		13.09M shares	12.77M shares

Balance Sheet

Concept	2021 Q4	2021 Q3	2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$11.67M	$23.17M	$39.10M
YoY Change	-62.34%	-40.74%	-27.32%
Cash & Equivalents	$11.67M	$23.17M	$39.09M
Short-Term Investments
Other Short-Term Assets	$9.293M	$7.398M	$11.10M
YoY Change	-28.52%	-33.35%	65.67%
Inventory
Prepaid Expenses
Receivables	$25.84M	$24.82M	$25.20M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$46.81M	$55.38M	$75.40M
YoY Change	-29.19%	-26.55%	-7.03%
LONG-TERM ASSETS
Property, Plant & Equipment	$749.9M	$756.1M	$783.2M
YoY Change	-3.4%	-3.46%	-3.44%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$26.31M	$20.67M	$19.30M
YoY Change	34.9%	7.1%	13.53%
Total Long-Term Assets	$776.2M	$776.8M	$802.6M
YoY Change	-2.45%	-3.21%	-3.1%
TOTAL ASSETS
Total Short-Term Assets	$46.81M	$55.38M	$75.40M
Total Long-Term Assets	$776.2M	$776.8M	$802.6M
Total Assets	$823.1M	$832.1M	$878.0M
YoY Change	-4.5%	-5.22%	-3.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$8.131M	$6.535M	$6.800M
YoY Change	17.84%	-3.9%	-4.23%
Accrued Expenses	$54.77M	$54.78M	$54.80M
YoY Change	-0.05%	-0.03%	-0.18%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due			$0.00
YoY Change
Total Short-Term Liabilities	$62.90M	$61.32M	$61.60M
YoY Change	1.95%	-0.46%	-0.65%
LONG-TERM LIABILITIES
Long-Term Debt	$398.1M	$397.7M	$396.2M
YoY Change	0.38%	0.39%	0.41%
Other Long-Term Liabilities	$10.90M	$19.48M	$23.70M
YoY Change	-50.47%	-17.82%	-9.2%
Total Long-Term Liabilities	$409.0M	$417.2M	$419.9M
YoY Change	-2.29%	-0.64%	-0.19%
TOTAL LIABILITIES
Total Short-Term Liabilities	$62.90M	$61.32M	$61.60M
Total Long-Term Liabilities	$409.0M	$417.2M	$419.9M
Total Liabilities	$471.9M	$478.5M	$481.6M
YoY Change	-1.74%	-0.63%	-0.23%
SHAREHOLDERS EQUITY
Retained Earnings	-$350.7M	-$345.6M	-$288.6M
YoY Change	14.65%	19.73%	12.05%
Common Stock	$133.0K	$133.0K	$129.0K
YoY Change	3.1%	3.1%	-58.39%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$339.0M	$343.6M	$394.5M
YoY Change
Total Liabilities & Shareholders Equity	$823.1M	$832.1M	$878.0M
YoY Change	-4.5%	-5.22%	-3.45%

Cashflow Statement

Concept	2021 Q4	2021 Q3	2020 Q3
OPERATING ACTIVITIES
Net Income	-$3.755M	-$11.12M	-$12.29M
YoY Change	-77.38%	-9.47%	155.52%
Depreciation, Depletion And Amortization	$7.657M	$7.851M	$8.640M
YoY Change	-0.3%	-9.13%	10.77%
Cash From Operating Activities	-$3.605M	$1.086M	-$1.890M
YoY Change	-52.31%	-157.46%	5.59%
INVESTING ACTIVITIES
Capital Expenditures	-$1.377M	-$884.0K	-$1.710M
YoY Change	129.5%	-48.3%	-95.33%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$1.377M	-$884.0K	-$1.710M
YoY Change	129.5%	-48.3%	-95.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.370M	568.0K	-330.0K
YoY Change	114.06%	-272.12%	65.0%
NET CHANGE
Cash From Operating Activities	-3.605M	1.086M	-1.890M
Cash From Investing Activities	-1.377M	-884.0K	-1.710M
Cash From Financing Activities	-1.370M	568.0K	-330.0K
Net Change In Cash	-6.352M	770.0K	-3.930M
YoY Change	-27.82%	-119.59%	-89.82%
FREE CASH FLOW
Cash From Operating Activities	-$3.605M	$1.086M	-$1.890M
Capital Expenditures	-$1.377M	-$884.0K	-$1.710M
Free Cash Flow	-$2.228M	$1.970M	-$180.0K
YoY Change	-67.99%	-1194.44%	-100.52%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001595527
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Amendment Flag AmendmentFlag	false
CY2020Q3	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.4115
CY2020Q3	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.4115
	nycr	Advisory Agreement Board Of Directors Approval Percentage AdvisoryAgreementBoardOfDirectorsApprovalPercentage	0.66
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2021-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-39448
	dei	Entity Registrant Name EntityRegistrantName	New York City REIT, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-4380248
	dei	Entity Address Address Line1 EntityAddressAddressLine1	650 Fifth Ave.,
	dei	Entity Address Address Line2 EntityAddressAddressLine2	30th Floor
	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10019
	dei	City Area Code CityAreaCode	212
	dei	Local Phone Number LocalPhoneNumber	415-6500
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2021Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	13277739	shares
CY2021Q3	us-gaap	Land Land	193357000	USD
CY2020Q4	us-gaap	Land Land	193658000	USD
CY2021Q3	nycr	Buildings Fixturesand Improvements BuildingsFixturesandImprovements	570355000	USD
CY2020Q4	nycr	Buildings Fixturesand Improvements BuildingsFixturesandImprovements	568861000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Asset Acquired In Place Leases FiniteLivedIntangibleAssetAcquiredInPlaceLeases	97375000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Asset Acquired In Place Leases FiniteLivedIntangibleAssetAcquiredInPlaceLeases	98118000	USD
CY2021Q3	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	861087000	USD
CY2020Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	860637000	USD
CY2021Q3	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	160217000	USD
CY2020Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	139666000	USD
CY2021Q3	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	700870000	USD
CY2020Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	720971000	USD
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	23169000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	30999000	USD
CY2021Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	11611000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	8995000	USD
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	55219000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	55375000	USD
CY2021Q3	us-gaap	Due From Related Parties DueFromRelatedParties	0	USD
CY2020Q4	us-gaap	Due From Related Parties DueFromRelatedParties	435000	USD
CY2021Q3	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	7398000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	12953000	USD
CY2021Q3	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	24817000	USD
CY2020Q4	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	22050000	USD
CY2021Q3	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	9059000	USD
CY2020Q4	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	10503000	USD
CY2021Q3	us-gaap	Assets Assets	832143000	USD
CY2020Q4	us-gaap	Assets Assets	861846000	USD
CY2021Q3	nycr	Secured Debt Netof Deferred Financing Costs SecuredDebtNetofDeferredFinancingCosts	397731000	USD
CY2020Q4	nycr	Secured Debt Netof Deferred Financing Costs SecuredDebtNetofDeferredFinancingCosts	396574000	USD
CY2021Q3	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	33000	USD
CY2020Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	0	USD
CY2021Q3	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	6535000	USD
CY2020Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	6916000	USD
CY2021Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	54783000	USD
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	54820000	USD
CY2021Q3	us-gaap	Below Market Lease Net BelowMarketLeaseNet	12362000	USD
CY2020Q4	us-gaap	Below Market Lease Net BelowMarketLeaseNet	14006000	USD
CY2021Q3	us-gaap	Derivative Liabilities DerivativeLiabilities	2330000	USD
CY2020Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	3405000	USD
CY2021Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	4784000	USD
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	4558000	USD
CY2021Q3	us-gaap	Liabilities Liabilities	478525000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	480279000	USD
CY2021Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2021Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2021Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13277738	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	13277738	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12802690	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12802690	shares
CY2021Q3	us-gaap	Common Stock Value CommonStockValue	133000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	129000	USD
CY2021Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	691344000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	686715000	USD
CY2021Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2330000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3404000	USD
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-345584000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-305882000	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	343563000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	377558000	USD
CY2021Q3	us-gaap	Minority Interest MinorityInterest	10055000	USD
CY2020Q4	us-gaap	Minority Interest MinorityInterest	4009000	USD
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	353618000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	381567000	USD
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	832143000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	861846000	USD
CY2021Q3	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	15848000	USD
CY2020Q3	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	16997000	USD
	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	46011000	USD
	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	53035000	USD
CY2021Q3	nycr	Asset And Property Management Fees To Related Parties AssetAndPropertyManagementFeesToRelatedParties	1862000	USD
CY2020Q3	nycr	Asset And Property Management Fees To Related Parties AssetAndPropertyManagementFeesToRelatedParties	1879000	USD
	nycr	Asset And Property Management Fees To Related Parties AssetAndPropertyManagementFeesToRelatedParties	5616000	USD
	nycr	Asset And Property Management Fees To Related Parties AssetAndPropertyManagementFeesToRelatedParties	5721000	USD
CY2021Q3	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	8029000	USD
CY2020Q3	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	8300000	USD
	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	25088000	USD
	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	23533000	USD
CY2021Q3	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	413000	USD
CY2020Q3	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	USD
	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	413000	USD
	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	USD
CY2021Q3	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0	USD
CY2020Q3	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0	USD
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0	USD
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0	USD
CY2021Q3	nycr	Stock Issuance Expense StockIssuanceExpense	0	USD
CY2020Q3	nycr	Stock Issuance Expense StockIssuanceExpense	1299000	USD
	nycr	Stock Issuance Expense StockIssuanceExpense	0	USD
	nycr	Stock Issuance Expense StockIssuanceExpense	1299000	USD
CY2021Q3	nycr	Vesting And Conversion Expense VestingAndConversionExpense	0	USD
CY2020Q3	nycr	Vesting And Conversion Expense VestingAndConversionExpense	1153000	USD
	nycr	Vesting And Conversion Expense VestingAndConversionExpense	0	USD
	nycr	Vesting And Conversion Expense VestingAndConversionExpense	1153000	USD
CY2021Q3	us-gaap	Share Based Compensation ShareBasedCompensation	2121000	USD
CY2020Q3	us-gaap	Share Based Compensation ShareBasedCompensation	1711000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	6356000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1758000	USD
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1884000	USD
CY2020Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1234000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6600000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5727000	USD
CY2021Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	7851000	USD
CY2020Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	8639000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	23400000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	24070000	USD
CY2021Q3	us-gaap	Costs And Expenses CostsAndExpenses	22160000	USD
CY2020Q3	us-gaap	Costs And Expenses CostsAndExpenses	24215000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	67473000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	63261000	USD
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-6312000	USD
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-7218000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-21462000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-10226000	USD
CY2021Q3	us-gaap	Interest Expense InterestExpense	4803000	USD
CY2020Q3	us-gaap	Interest Expense InterestExpense	5089000	USD
	us-gaap	Interest Expense InterestExpense	14279000	USD
	us-gaap	Interest Expense InterestExpense	14915000	USD
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	5000	USD
CY2020Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	19000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	44000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	779000	USD
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4798000	USD
CY2020Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5070000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-14235000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-14136000	USD
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11110000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-12288000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-35697000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-24362000	USD
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	14000	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	14000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11124000	USD
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-12288000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-35711000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-24362000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	252000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	264000	USD
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	1074000	USD
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-2395000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	252000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	264000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1074000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2395000	USD
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-10872000	USD
CY2020Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-12024000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-34637000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-26757000	USD
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13093486	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13093486	shares
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12772176	shares
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12772176	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12892382	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12892382	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12757376	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12757376	shares
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.85
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.85
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.96
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.96
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.78
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.78
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.91
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.91
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	381567000	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	4506000	USD
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	183000	USD
	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	0	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	6356000	USD
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.10
	us-gaap	Dividends Dividends	3871000	USD
	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	120000	USD
	us-gaap	Profit Loss ProfitLoss	-35711000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1074000	USD
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	353618000	USD
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	362055000	USD
CY2021Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1663000	USD
CY2021Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	0	USD
CY2021Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2121000	USD
CY2021Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.10
CY2021Q3	us-gaap	Dividends Dividends	1309000	USD
CY2021Q3	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	40000	USD
CY2021Q3	us-gaap	Profit Loss ProfitLoss	-11124000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	252000	USD
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	353618000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	420549000	USD
	nycr	Stock Redeemed During Period Value StockRedeemedDuringPeriodValue	328000	USD
	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	1153000	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1758000	USD
	us-gaap	Profit Loss ProfitLoss	-24362000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2395000	USD
CY2020Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	396375000	USD
CY2020Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	405863000	USD
CY2020Q3	nycr	Stock Redeemed During Period Value StockRedeemedDuringPeriodValue	328000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	1153000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	1711000	USD
CY2020Q3	us-gaap	Profit Loss ProfitLoss	-12288000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	264000	USD
CY2020Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	396375000	USD
	us-gaap	Profit Loss ProfitLoss	-35711000	USD
	us-gaap	Profit Loss ProfitLoss	-24362000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	23400000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	24070000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1157000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1157000	USD
	nycr	Accretionand Amortizationof Belowand Above Market Lease Intangible Assetsand Liabilities AccretionandAmortizationofBelowandAboveMarketLeaseIntangibleAssetsandLiabilities	807000	USD
	nycr	Accretionand Amortizationof Belowand Above Market Lease Intangible Assetsand Liabilities AccretionandAmortizationofBelowandAboveMarketLeaseIntangibleAssetsandLiabilities	2807000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	6356000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1758000	USD
	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	413000	USD
	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	USD
	nycr	Vesting And Conversion Expense VestingAndConversionExpense	0	USD
	nycr	Vesting And Conversion Expense VestingAndConversionExpense	1153000	USD
	us-gaap	Increase Decrease In Leasing Receivables IncreaseDecreaseInLeasingReceivables	2816000	USD
	us-gaap	Increase Decrease In Leasing Receivables IncreaseDecreaseInLeasingReceivables	3582000	USD
	nycr	Increase Decreasein Straight Line Rent Payable IncreaseDecreaseinStraightLineRentPayable	82000	USD
	nycr	Increase Decreasein Straight Line Rent Payable IncreaseDecreaseinStraightLineRentPayable	82000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-3891000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4232000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-502000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-496000	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	226000	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1240000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4311000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6019000	USD
	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	1998000	USD
	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	3162000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1998000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3162000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5269000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	3871000	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	0	USD
	nycr	Payment For Redemption Of Stock PaymentForRedemptionOfStock	0	USD
	nycr	Payment For Redemption Of Stock PaymentForRedemptionOfStock	328000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	183000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	120000	USD
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1095000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-328000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5214000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-9509000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	39994000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	58297000	USD
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	34780000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	48788000	USD
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	23169000	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	39088000	USD
CY2021Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	11611000	USD
CY2020Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	9700000	USD
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	34780000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	48788000	USD
	nycr	Noncashor Part Noncash Accrued Capital Expenditures NoncashorPartNoncashAccruedCapitalExpenditures	121000	USD
	nycr	Noncashor Part Noncash Accrued Capital Expenditures NoncashorPartNoncashAccruedCapitalExpenditures	294000	USD
CY2021Q3	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	8	property
CY2021Q3	us-gaap	Net Rentable Area NetRentableArea	1200000	sqft
CY2021Q3	nycr	Aggregate Purchase Priceof Real Estate AggregatePurchasePriceofRealEstate	790700000	USD
	nycr	Stock Issuance Expense StockIssuanceExpense	1300000	USD
CY2020Q3	nycr	Stock Issuance Expense StockIssuanceExpense	1300000	USD
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Management makes significant estimates regarding revenue recognition, purchase price allocations to record investments in real estate, and fair value measurements, as applicable.</span></div>
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	8500000	USD
	nycr	Lessor Operating Lease Weighted Average Remaining Lease Term LessorOperatingLeaseWeightedAverageRemainingLeaseTerm	P6Y9M18D
CY2020Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	400000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	500000	USD
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	8500000	USD
CY2021Q3	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	400000	USD
CY2021Q3	us-gaap	Debt Instrument Collateral Amount DebtInstrumentCollateralAmount	829300000	USD
CY2021Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	0	USD
CY2021Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	0	USD
CY2021Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0	USD
CY2021Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	55000000	USD
CY2021Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	0	USD
CY2021Q3	nycr	Long Term Debt Maturity After Year Four LongTermDebtMaturityAfterYearFour	350000000	USD
CY2021Q3	us-gaap	Secured Debt SecuredDebt	405000000	USD
CY2021Q3	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	0	USD
CY2021Q3	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	2330000	USD
CY2021Q3	us-gaap	Derivative Asset Collateral Obligation To Return Cash Offset DerivativeAssetCollateralObligationToReturnCashOffset	0	USD
CY2021Q3	us-gaap	Derivative Liabilities DerivativeLiabilities	2330000	USD
CY2021Q3	us-gaap	Derivative Collateral Right To Reclaim Securities DerivativeCollateralRightToReclaimSecurities	0	USD
CY2021Q3	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	0	USD
CY2021Q3	us-gaap	Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral	2330000	USD
CY2020Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	0	USD
CY2020Q4	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	3405000	USD
CY2020Q4	us-gaap	Derivative Asset Collateral Obligation To Return Cash Offset DerivativeAssetCollateralObligationToReturnCashOffset	0	USD
CY2020Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	3405000	USD
CY2020Q4	us-gaap	Derivative Collateral Right To Reclaim Securities DerivativeCollateralRightToReclaimSecurities	0	USD
CY2020Q4	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	0	USD
CY2020Q4	us-gaap	Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral	3405000	USD
CY2021Q3	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	-2500000	USD
CY2021Q3	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	-2500000	USD
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	13300000	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12800000	shares
	nycr	Common Stock Dividends Per Share Declared Annualized CommonStockDividendsPerShareDeclaredAnnualized	0.40
CY2021Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.10
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.04889
CY2021Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.10
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q3	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	6672	shares
CY2020Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	300000	USD
CY2020	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	1200000	USD
CY2021Q3	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0	shares
	nycr	Distribution Reinvestment Plan Termination Notice Period DistributionReinvestmentPlanTerminationNoticePeriod	P10D
CY2021Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P45Y3M18D
CY2021Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.086
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	55200000	USD
CY2021Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	54800000	USD
CY2021Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	1200000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	3600000	USD
CY2021Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	1200000	USD
	us-gaap	Operating Lease Expense OperatingLeaseExpense	3600000	USD
CY2020Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	1200000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	3600000	USD
CY2020Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	1200000	USD
	us-gaap	Operating Lease Expense OperatingLeaseExpense	3600000	USD
CY2020Q3	nycr	Vesting And Conversion Expense VestingAndConversionExpense	1200000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	1187000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	4746000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	4746000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	4746000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	4746000	USD
CY2021Q3	nycr	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	202500000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	222671000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	167888000	USD
CY2021Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	54783000	USD
	nycr	Advisory Agreement Renewal Term AdvisoryAgreementRenewalTerm	P5Y
CY2018Q4	nycr	Period Prior To Expiration Date Needed To Terminate Agreement PeriodPriorToExpirationDateNeededToTerminateAgreement	P180D
	nycr	Related Party Transaction Asset Management Fee Percentageof Benchmark RelatedPartyTransactionAssetManagementFeePercentageofBenchmark	0.0125
	nycr	Vesting And Conversion Expense VestingAndConversionExpense	1200000	USD
CY2021Q3	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	2926000	USD
CY2020Q3	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	2506000	USD
	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	9047000	USD
	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	8576000	USD
CY2021Q3	us-gaap	Related Party Transaction Due From To Related Party RelatedPartyTransactionDueFromToRelatedParty	-33000	USD
CY2020Q4	us-gaap	Related Party Transaction Due From To Related Party RelatedPartyTransactionDueFromToRelatedParty	435000	USD
	nycr	Consecutive Trading Dates Commencing Converted Shares ConsecutiveTradingDatesCommencingConvertedShares	P180D
CY2021Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2100000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6300000	USD
CY2020Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1700000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1700000	USD
	nycr	Distributions On The Ltip Unit DistributionsOnTheLTIPUnit	0.10
	nycr	Distribution On The Earned Ltip Unit DistributionOnTheEarnedLTIPUnit	0.90
	nycr	Sharebased Compensation Arrangementby Sharebased Payment Award Shares Issuedin Period In Lieu Of Cash SharebasedCompensationArrangementbySharebasedPaymentAwardSharesIssuedinPeriodInLieuOfCash	0	shares
	nycr	Sharebased Compensation Arrangementby Sharebased Payment Award Shares Issuedin Period In Lieu Of Cash SharebasedCompensationArrangementbySharebasedPaymentAwardSharesIssuedinPeriodInLieuOfCash	0	shares
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11124000	USD
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-12288000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-35711000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-24362000	USD
CY2021Q3	us-gaap	Dilutive Securities DilutiveSecurities	-40000	USD
CY2020Q3	us-gaap	Dilutive Securities DilutiveSecurities	0	USD
	us-gaap	Dilutive Securities DilutiveSecurities	-120000	USD
	us-gaap	Dilutive Securities DilutiveSecurities	0	USD
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-11164000	USD
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-12288000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-35831000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-24362000	USD
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13093486	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13093486	shares
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12772176	shares
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12772176	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12892382	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12892382	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12757376	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12757376	shares
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.85
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.85
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.96
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.96
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.78
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.78
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.91
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.91
CY2021Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4038184	shares
CY2020Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	89770	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4035111	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	77394	shares

Files In Submission

Name	View Source	Status
0001595527-21-000027-index-headers.html	Edgar Link	pending
0001595527-21-000027-index.html	Edgar Link	pending
0001595527-21-000027.txt	Edgar Link	pending
0001595527-21-000027-xbrl.zip	Edgar Link	pending
ex311nycr9302021.htm	Edgar Link	pending
ex312nycr9302021.htm	Edgar Link	pending
ex32nycr93021.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nycr-20210930.htm	Edgar Link	pending
nycr-20210930.xsd	Edgar Link	pending
nycr-20210930_cal.xml	Edgar Link	unprocessable
nycr-20210930_def.xml	Edgar Link	unprocessable
nycr-20210930_g1.jpg	Edgar Link	pending
nycr-20210930_htm.xml	Edgar Link	completed
nycr-20210930_lab.xml	Edgar Link	unprocessable
nycr-20210930_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NYC
American Strategic Investment Co. Stock $nyc

2021 Q4 Form 10-Q Financial Statement

#000159552721000027 Filed on November 12, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NYC American Strategic Investment Co. Stock $nyc

2021 Q4 Form 10-Q Financial Statement

#000159552721000027 Filed on November 12, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NYC
American Strategic Investment Co. Stock $nyc